Credit Suisse’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-55,566
| Closed | -$635K | – | 3783 |
|
|
2017
Q3 | $635K | Buy |
55,566
+41,407
| +292% | +$473K | ﹤0.01% | 2939 |
|
|
2017
Q2 | $138K | Sell |
14,159
-33,445
| -70% | -$326K | ﹤0.01% | 3299 |
|
|
2017
Q1 | $1.15M | Buy |
47,604
+21,762
| +84% | +$528K | ﹤0.01% | 2422 |
|
|
2016
Q4 | $829K | Sell |
25,842
-19,542
| -43% | -$627K | ﹤0.01% | 2813 |
|
|
2016
Q3 | $2.27M | Sell |
45,384
-3,153
| -6% | -$158K | ﹤0.01% | 2007 |
|
|
2016
Q2 | $2.06M | Buy |
48,537
+2,542
| +6% | +$108K | ﹤0.01% | 2068 |
|
|
2016
Q1 | $3.03M | Buy |
45,995
+5,459
| +13% | +$360K | ﹤0.01% | 1686 |
|
|
2015
Q4 | $2.52M | Buy |
40,536
+3,013
| +8% | +$187K | ﹤0.01% | 1953 |
|
|
2015
Q3 | $2.51M | Sell |
37,523
-18,616
| -33% | -$1.25M | ﹤0.01% | 1936 |
|
|
2015
Q2 | $5.46M | Buy |
56,139
+12,291
| +28% | +$1.2M | 0.01% | 1516 |
|
|
2015
Q1 | $4.1M | Sell |
43,848
-27,542
| -39% | -$2.57M | ﹤0.01% | 1635 |
|
|
2014
Q4 | $6.35M | Buy |
71,390
+1,819
| +3% | +$162K | 0.01% | 1362 |
|
|
2014
Q3 | $4.81M | Buy |
69,571
+6,483
| +10% | +$448K | ﹤0.01% | 1528 |
|
|
2014
Q2 | $3.62M | Buy |
63,088
+37,002
| +142% | +$2.12M | ﹤0.01% | 1919 |
|
|
2014
Q1 | $1.04M | Sell |
26,086
-78,111
| -75% | -$3.1M | ﹤0.01% | 2758 |
|
|
2013
Q4 | $4.37M | Sell |
104,197
-291,548
| -74% | -$12.2M | ﹤0.01% | 1680 |
|
|
2013
Q3 | $11.8M | Sell |
395,745
-189,831
| -32% | -$5.66M | 0.01% | 864 |
|
|
2013
Q2 | $31.1M | Buy |
+585,576
| New | +$31.1M | 0.03% | 476 |
|